Literature DB >> 17073742

Negative regulation of leucocyte functions by CD33-related siglecs.

T Avril1, H Attrill, J Zhang, A Raper, P R Crocker.   

Abstract

The siglecs (sialic acid-binding Ig-like lectins) are a family of transmembrane receptors expressed in the haemopoietic, immune and nervous systems. The CD33-related siglecs are a distinct subset mostly expressed in the innate immune system where they can function as inhibitory receptors by suppressing the signalling mediated by receptors coupled with ITAMs (immunoreceptor tyrosine-based activation motifs). CD33-related siglecs contain ITIMs (immunoreceptor tyrosine-based inhibitory motifs) that recruit and activate SHP-1 [SH2 (Src homology 2) domain-containing phosphatase-1] and SHP-2. In addition, the ITIMs of CD33-related siglecs can suppress siglec-dependent adhesion of sialylated ligands and mediate endocytosis. Siglec-H is a recently characterized murine CD33-related endocytic receptor that lacks intrinsic tyrosine-based signalling motifs and is expressed selectively on PDCs (plasmacytoid dendritic cells). Siglec-H depends on DAP12 (DNAX-activating protein of 12 kDa) for surface expression and cross-linking with anti-siglec-H antibodies can selectively inhibit interferon-alpha production by PDCs following TLR9 (Toll-like receptor 9) ligation. Thus CD33-related siglecs are able to mediate diverse inhibitory functions of leucocytes in the innate immune system via both ITIM-dependent and -independent pathways.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17073742     DOI: 10.1042/BST0341024

Source DB:  PubMed          Journal:  Biochem Soc Trans        ISSN: 0300-5127            Impact factor:   5.407


  25 in total

Review 1.  Evolution of CD33-related siglecs: regulating host immune functions and escaping pathogen exploitation?

Authors:  Huan Cao; Paul R Crocker
Journal:  Immunology       Date:  2010-11-11       Impact factor: 7.397

2.  Bone marrow aspirate and biopsy: a pathologist's perspective. II. interpretation of the bone marrow aspirate and biopsy.

Authors:  Roger S Riley; David Williams; Micaela Ross; Shawn Zhao; Alden Chesney; Bradly D Clark; Jonathan M Ben-Ezra
Journal:  J Clin Lab Anal       Date:  2009       Impact factor: 2.352

Review 3.  Siglec-8 as a drugable target to treat eosinophil and mast cell-associated conditions.

Authors:  Takumi Kiwamoto; Norihito Kawasaki; James C Paulson; Bruce S Bochner
Journal:  Pharmacol Ther       Date:  2012-06-27       Impact factor: 12.310

4.  SIGLEC12, a human-specific segregating (pseudo)gene, encodes a signaling molecule expressed in prostate carcinomas.

Authors:  Nivedita Mitra; Kalyan Banda; Tasha K Altheide; Lana Schaffer; Teresa L Johnson-Pais; Joke Beuten; Robin J Leach; Takashi Angata; Nissi Varki; Ajit Varki
Journal:  J Biol Chem       Date:  2011-05-09       Impact factor: 5.157

Review 5.  Basic and clinical immunology of Siglecs.

Authors:  Stephan von Gunten; Bruce S Bochner
Journal:  Ann N Y Acad Sci       Date:  2008-11       Impact factor: 5.691

6.  Genome-wide gene expression profiling reveals unsuspected molecular alterations in pemphigus foliaceus.

Authors:  Danielle Malheiros; Rodrigo A Panepucci; Ana M Roselino; Amélia G Araújo; Marco A Zago; Maria Luiza Petzl-Erler
Journal:  Immunology       Date:  2014-11       Impact factor: 7.397

7.  Group B Streptococcus suppression of phagocyte functions by protein-mediated engagement of human Siglec-5.

Authors:  Aaron F Carlin; Yung-Chi Chang; Thomas Areschoug; Gunnar Lindahl; Nancy Hurtado-Ziola; Charles C King; Ajit Varki; Victor Nizet
Journal:  J Exp Med       Date:  2009-07-13       Impact factor: 14.307

8.  Differences in the constitutive and SIV infection induced expression of Siglecs by hematopoietic cells from non-human primates.

Authors:  Jiraporn Jaroenpool; Kenneth A Rogers; Kovit Pattanapanyasat; Francois Villinger; Nattawat Onlamoon; Paul R Crocker; Aftab A Ansari
Journal:  Cell Immunol       Date:  2008-03-10       Impact factor: 4.868

9.  Anti-Siglec-F antibody inhibits oral egg allergen induced intestinal eosinophilic inflammation in a mouse model.

Authors:  Dae Jin Song; Jae Youn Cho; Marina Miller; Wendy Strangman; Mai Zhang; Ajit Varki; David H Broide
Journal:  Clin Immunol       Date:  2009-01-08       Impact factor: 3.969

10.  Genetic and biochemical modulation of sialic acid O-acetylation on group B Streptococcus: phenotypic and functional impact.

Authors:  Shannon Weiman; Samira Dahesh; Aaron F Carlin; Ajit Varki; Victor Nizet; Amanda L Lewis
Journal:  Glycobiology       Date:  2009-07-30       Impact factor: 4.313

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.